InsiderTrades

Form 4 for PFE Pfizer

Accepted 2025-03-06 00:00:00 ET · period of report 2025-02-27 · accession 0001225208-25-003073 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-06 2025-02-27 PFE DAMICO JENNIFER B. SVP, Ctrl F - Tax $26.10 -749 29.8K -2% -$19.5K
D 2025-03-06 2025-03-04 PFE DAMICO JENNIFER B. SVP, Ctrl A - Grant $0.00 +5,583 14.3K +64% $0
D 2025-03-06 2025-03-04 PFE DAMICO JENNIFER B. SVP, Ctrl S - Sale $25.93 -2,500 11.8K -17% -$64.8K
D 2025-03-06 2025-03-04 PFE DAMICO JENNIFER B. SVP, Ctrl A - Grant $0.00 +47.5K 47.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-27 F D 749 $26.10 29,761 D — — (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
2 Common Common Stock 2025-03-04 A A 5,583 $0.00 14,350 D — — (F2) The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
3 Common Common Stock 2025-03-04 S D 2,500 $25.93 11,850 D — —
4 Derivative Stock Appreciation Rights 2025-03-04 A A 47,511 $0.00 47,511 D $25.75 · 2030-03-04 to 2030-03-04 47,511 Common Stock (F3) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.